Search

everythinglearnresearchcommunity

for

Search:↓

IVL-DrugFluidic® can mass-produce high-quality, long-acting injectable drug microspheres, improving patient compliance and reducing side effects.

Spironolactone helped reduce excessive facial hair in a woman with porphyria cutanea tarda.

Combining medication and minimally invasive techniques can effectively manage Marine-Lenhart syndrome.

50-mg ritlecitinib capsules are bioequivalent to 100-mg capsules.

Psychotropic medications can cause skin problems, including serious conditions, and patients should be monitored closely.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

An 87-year-old man showed unusual signs of Hodgkin lymphoma, primarily high calcium levels, which improved after treatment and revealed the disease.

Belimumab effectively controls SLE disease activity and reduces steroid use.

Bicalutamide improves hair density in women safely.

Bromhexine and spironolactone together reduced COVID-19 symptoms and hospitalization time without side effects.

Thallium poisoning can be treated successfully with the right antidote.

The new system greatly improves carvedilol's solubility and effectiveness.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Spironolactone can cause side effects like high potassium levels and breast enlargement, and patients need careful monitoring.

Topiramate may help improve disruptive behaviors in children with bipolar disorder.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

New drugs and combination therapies are improving treatment for lower urinary tract symptoms.

Finasteride is high-risk for cognitive disorders, while Carbidopa/Levodopa, Topiramate, and Clonazepam are moderate-risk.

Bicalutamide improved hair growth more than spironolactone in women with hair loss.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

Taking spironolactone and linestrenol for androgen excess can lead to lower bone density in young women.

Switching to extended-release divalproex sodium improved patient-reported tremor but did not change seizure frequency or most side effects.

Lamotrigine can cause hair loss.

Wnt-activating drugs generally do not increase cancer risk.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Certain medications can cause serious side effects, including skin reactions, stroke, muscle disorders, tongue swelling, hair loss in women, and liver failure.

Lamotrigine can cause hair loss in some patients.

Thalidomide significantly improved hair regrowth in a woman with lichen planopilaris.